Year-End Report

KING & SPALDING LLP for NCCR

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 3/S. 5, the Stem Cell Research Enhancement Act Biomedical research funding, including provisions in: H.R. 2764, Consolidated Appropriations Act of 2008 H.R. 3043/S. 1710, Labor/HHS/Education appropriations legislation

LobbyistCovered position, as disclosed
JASON S MCKITRICK BUDGET ANALYST, HOUSE BUDGET COMMITTEE
MARK H SMITH N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3043 (110th), H.R. 2764 (110th), S. 1710 (110th), S. 5 (110th), H.R. 3 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.